Bank of America’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-163,226
| Closed | -$555K | – | 6727 |
|
|
2018
Q3 | $555K | Sell |
163,226
-128,830
| -44% | -$438K | ﹤0.01% | 4205 |
|
|
2018
Q2 | $1.1M | Buy |
292,056
+106,737
| +58% | +$401K | ﹤0.01% | 3792 |
|
|
2018
Q1 | $758K | Sell |
185,319
-12,893
| -7% | -$52.7K | ﹤0.01% | 3936 |
|
|
2017
Q4 | $921K | Buy |
198,212
+83,507
| +73% | +$388K | ﹤0.01% | 3864 |
|
|
2017
Q3 | $815K | Buy |
114,705
+19,493
| +20% | +$139K | ﹤0.01% | 3952 |
|
|
2017
Q2 | $688K | Sell |
95,212
-13,346
| -12% | -$96.4K | ﹤0.01% | 4021 |
|
|
2017
Q1 | $669K | Sell |
108,558
-22,042
| -17% | -$136K | ﹤0.01% | 4043 |
|
|
2016
Q4 | $765K | Buy |
130,600
+7,086
| +6% | +$41.5K | ﹤0.01% | 3852 |
|
|
2016
Q3 | $656K | Sell |
123,514
-10,918
| -8% | -$58K | ﹤0.01% | 3772 |
|
|
2016
Q2 | $890K | Buy |
134,432
+13,794
| +11% | +$91.3K | ﹤0.01% | 3605 |
|
|
2016
Q1 | $563K | Sell |
120,638
-255,812
| -68% | -$1.19M | ﹤0.01% | 3804 |
|
|
2015
Q4 | $1.9M | Sell |
376,450
-286,545
| -43% | -$1.45M | ﹤0.01% | 3109 |
|
|
2015
Q3 | $2.33M | Buy |
662,995
+463,282
| +232% | +$1.63M | ﹤0.01% | 2936 |
|
|
2015
Q2 | $1.99M | Buy |
199,713
+71,883
| +56% | +$717K | ﹤0.01% | 2741 |
|
|
2015
Q1 | $1.63M | Buy |
127,830
+58,354
| +84% | +$743K | ﹤0.01% | 2711 |
|
|
2014
Q4 | $983K | Sell |
69,476
-230,689
| -77% | -$3.26M | ﹤0.01% | 3122 |
|
|
2014
Q3 | $4.13M | Buy |
300,165
+155,640
| +108% | +$2.14M | ﹤0.01% | 2118 |
|
|
2014
Q2 | $2.22M | Buy |
144,525
+48,352
| +50% | +$744K | ﹤0.01% | 2506 |
|
|
2014
Q1 | $1.64M | Sell |
96,173
-21,755
| -18% | -$371K | ﹤0.01% | 2656 |
|
|
2013
Q4 | $1.53M | Buy |
117,928
+37,423
| +46% | +$485K | ﹤0.01% | 2761 |
|
|
2013
Q3 | $813K | Sell |
80,505
-10,822
| -12% | -$109K | ﹤0.01% | 3148 |
|
|
2013
Q2 | $682K | Buy |
+91,327
| New | +$682K | ﹤0.01% | 3473 |
|